Sunny Kumar is a Partner at GSR Ventures, where he focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector. He is a physician as well as a published medical researcher with a focus on applying informatics and artificial intelligence to translational medicine in the fields of neurosurgery and gene therapy. Serial entrepreneur, he founded a company to reduce readmissions for high-risk chronic disease patients using voice-enabled natural language processing.
A graduate of Yale University, Sunny earned a BS in Molecular Biology and an MD from Stanford University School of Medicine. Markets are shaken to the core by some companies. They can transform whole industries and have a profound impact. However, such companies are rare and difficult to identify at an early stage. This episode gives us a glimpse into how funds looking for unicorns find these gems and decide which companies to back.
